MENA 2024 Recordings-Diabetes in Pregnancy- The Year in Review

Video Transcription

Video Summary

The session on "Diabetes in Pregnancy" highlighted recent literature, clinical insights, and advances in managing diabetes during pregnancy. Over the years, diabetes management in pregnancy has evolved significantly, with type 2 diabetes now surpassing type 1 in prevalence. Emphasizing a life course approach, the discussion underscored the importance of glycemic control before, during, and after pregnancy using technologies like continuous glucose monitoring (CGM). Studies indicate CGMs are safe and effective, with pregnant users experiencing better outcomes. The session noted the challenges in achieving optimal glucose targets during pregnancy and the potential benefits of metformin, particularly in cases where insulin may not be accessible or suitable. The session also advised caution with growth restrictions linked to diabetes management. It was noted that insulin remains the primary treatment, with guidelines supporting metformin for specific conditions. New technologies like pumps and hybrid closed-loop systems were explored, though not all are approved for pregnancy in the US. The talk concluded with a call for improved postpartum care, highlighting the deterioration in diabetes management after childbirth and the need for structured follow-up. Ongoing research and randomized trials aim to refine these strategies, promising better outcomes in diabetes-related pregnancy care.

Asset Subtitle

Dr. Aoife Egan

Keywords

diabetes in pregnancy

glycemic control

continuous glucose monitoring

metformin

insulin treatment

postpartum care

pregnancy outcomes